1 |
Lee JH. The association of obesity indices and cardiovascular risk in Korean type 2 diabetes. The Korean Journal of Obesity. 2013;22(4):212-214. http://dx.doi.org/10.7570/kjo.2013.22.4.212
DOI
|
2 |
Park JH, Jun EY, Kang MY, Joung YS, Kim GS. Symptom experience and quality of life in breast cancer survivors. Journal of Korean Academy of Nursing. 2009;39(5):613-621. http://dx.doi.org/10.4040/jkan.2009.39.5.613
DOI
|
3 |
Otte JL, Carpenter JS, Zhong X, Johnstone PA. Feasibility study of acupuncture for reducing sleep disturbances and hot flashes in postmenopausal breast cancer survivors. Clinical Nurse Specialist CNS. 2011; 25(5):228-236. http://dx.doi.org/10.1097/NUR.0b013e318229950b
DOI
|
4 |
Carson JW, Carson KM, Porter LS, Keefe FJ, Seewaldt VL. Yoga of awareness program for menopausal symptoms in breast cancer survivors: Results from a randomized trial. Supportive Care in Cancer. 2009;17(10):1301-1309. http://dx.doi.org/10.1007/s00520-009-0587-5
DOI
ScienceOn
|
5 |
Toulis KA, Tzellos T, Kouvelas D, Goulis DG. Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: A systematic review and meta-analysis. Clinical Therapeutics. 2009;31(2):221-235. http://dx.doi.org/10.1016/j.clinthera.2009.02.006
DOI
|
6 |
Park J. Symptom cluster and status of physical function in women with breast cancer receiving chemotheraopy [master's thesis]. Seoul: Seoul National University; 2009.
|
7 |
Park H, Yoon HG. Menopausal symptoms, sexual function, depression, and quality of life in Korean patients with breast cancer receiving chemotherapy. Supportive Care in Cancer. 2013;21(9):2499-2507. http://dx.doi.org/10.1007/s00520-013-1815-6
DOI
|
8 |
Kwon EJ, Yi M. Distress and quality of life in breast cancer survivors in Korea. Asian Oncology Nursing. 2012;12(4):289-296. http://dx.doi.org/10.5388/aon.2012.12.4.289
DOI
ScienceOn
|
9 |
Hwang SY. Factors affecting quality of life among breast cancer survivors. Mental Health & Social Work. 2009;33:257-287.
|
10 |
Mao JJ, Stricker C, Bruner D, Xie S, Bowman MA, Farrar JT, et al. Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors. Cancer. 2009;115(16):3631-3639. http://dx.doi.org/10.1002/cncr.24419
DOI
ScienceOn
|
11 |
Yun YH, Mendoza TR, Heo DS, Yoo T, Heo BY, Park HA, et al. Development of a cancer pain assessment tool in Korea: A validation study of a Korean version of the brief pain inventory. Oncology. 2004;66(6):439-444. http://dx.doi.org/10.1159/000079497
DOI
ScienceOn
|
12 |
Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behavior Research Methods. 2009;41(4):1149-1160. http://dx.doi.org/10.3758/brm.41.4.1149
DOI
ScienceOn
|
13 |
Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The functional assessment of cancer therapy scale: Development and validation of the general measure. Journal of Clinical Oncology. 1993;11(3): 570-579.
DOI
|
14 |
Heinemann K, Ruebig A, Potthoff P, Schneider HP, Strelow F, Heinemann LA, et al. The menopause rating scale (MRS) scale: A methodological review. Health and Quality of Life Outcomes. 2004;2:45. http://dx.doi.org/10.1186/1477-7525-2-45
DOI
ScienceOn
|
15 |
Yoo HJ, Ahn SH, Eremenco S, Kim H, Kim WK, Kim SB, et al. Korean translation and validation of the functional assessment of cancer therapy- breast (FACT-B) scale version 4. Quality of Life Research. 2005;14 (6):1627-1632.
DOI
ScienceOn
|
16 |
Cleeland CS, Ryan KM. Pain assessment: Global use of the brief pain inventory. Annals of the Academy of Medicine Singapore. 1994;23(2): 129-138.
|
17 |
Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain. 1995;61(2):277-284.
DOI
ScienceOn
|
18 |
Reimer T, Gerber B. Quality-of-life considerations in the treatment of early-stage breast cancer in the elderly. Drugs and Aging. 2010;27(10): 791-800. http://dx.doi.org/10.2165/11584700-000000000-00000
DOI
|
19 |
Safarinejad MR, Shafiei N, Safarinejad S. Quality of life and sexual functioning in young women with early-stage breast cancer 1 year after lumpectomy. Psycho-Oncology. 2013;22(6):1242-1248. http://dx.doi.org/10.1002/pon.3130
DOI
|
20 |
Fenlon DR, Corner JL, Haviland J. Menopausal hot flushes after breast cancer. European Journal of Cancer Care. 2009;18(2):140-148. http://dx.doi.org/10.1111/j.1365-2354.2007.00902.x
DOI
|
21 |
Seo HJ. A comparison of the cancer incidence rates between KCCR's registered cancer statistics and NHIC's data of insurance claims [master's thesis]. Seoul: Korea University; 2012.
|
22 |
Oberguggenberger A, Hubalek M, Sztankay M, Meraner V, Beer B, Oberacher H, et al. Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs). Breast Cancer Research and Treatment. 2011;128(2):553-561. http://dx.doi.org/10.1007/s10549-011-1378-5
DOI
|
23 |
Korean Breast Cancer Society. The breast. 2nd ed. Seoul: Ilchokak Publishing Co.; 2005.
|
24 |
Dorjgochoo T, Gu K, Kallianpur A, Zheng Y, Zheng W, Chen Z, et al. Menopausal symptoms among breast cancer patients 6 months after diagnosis: A report from the Shanghai breast cancer survival study. Menopause (New York, NY). 2009;16(6):1205-1212. http://dx.doi.org/10.1097/gme.0b013e3181aac32b
DOI
|
25 |
Patterson RE, Saquib N, Natarajan L, Rock CL, Parker BA, Thomson CA, et al. Improvement in self-reported physical health predicts longer survival among women with a history of breast cancer. Breast Cancer Research and Treatment. 2011;127(2):541-547. http://dx.doi.org/10.1007/s10549-010-1236-x
DOI
|
26 |
Fontaine C, Meulemans A, Huizing M, Collen C, Kaufman L, De Mey J, et al. Tolerance of adjuvant letrozole outside of clinical trials. Breast (Edinburgh, Scotland). 2008;17(4):376-381. http://dx.doi.org/10.1016/j.breast.2008.02.006
DOI
|
27 |
Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: Patient-level meta-analysis of randomised trials. Lancet. 2011;378(9793):771-784. http://dx.doi.org/10.1016/s0140-6736(11)60993-8
DOI
ScienceOn
|